Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis.

Alessandro GiolloGiovanni CioffiFederica OgnibeniGiovanni OrsoliniAndrea DalbeniRiccardo BixioGiovanni AdamiAngelo FassioLuca IdolazziDavide GattiMaurizio RossiniOmbretta Viapiana

Published in: Arthritis research & therapy (2021)

Long-term treatment with TNFi was associated with reduced aortic stiffness progression in patients with established RA and several CVD risk factors.

Keyphrases

rheumatoid arthritis
risk factors
aortic valve
disease activity
left ventricular
pulmonary artery
aortic dissection
ankylosing spondylitis
interstitial lung disease
heart failure
coronary artery
idiopathic pulmonary fibrosis
atrial fibrillation